RE:RE:RE:RE:Inflation Reduction Act (IRA) boosts biological drugs Nice capulation of the upcoming & changing trends in cancer care.
Oncolytics biotech, fit into 4 of the 4, categories.
Yes Onc has been around 20+ years.
however the technology & science to support the co- therapeutic use, is certainly on the upswing.
Utilizing & understanding the 4 points
Targeted therapy, precision medicine, oncokytics viruses, liquid biopsies.
All in some form related to ONCs Pelareorep.
There is a lot more " value" than then known.
upcoming pancreatic cancer co- therapy with Roche.
mbc cancer therapy
The CAR-t , studies are still in the background.
Not discussed, but the immunotherapy opportunities are yet to be explored.
They have seen inate adaptation of Pelareorep affects on the imune system.
AkA, cancer vaccination.
Long way out, but not impossible.
It has long been known that everyone has cancer cells in our body at all times.
majority of the time the imune system fights it off.
enough of that.